The Tumor Microenvironment and Metastasis (TMM) Program is the newest Program at the IU Simon Cancer Center (IUSCC);it arose from our strategic plan and from existing collaborations in a working group originally based in the HMI Program, where interactive investigators looked at solid tumors and metastatic processes. The research goals of TMM are to: 1) advance our basic understanding of the role of cancer cell stromal interactions in cancer initiation, progression and metastasis, 2) evaluate the functions of the metastatic niche, and 3) translate discoveries of the pathobiology of solid tumors, the tumor microenvironment, and the metastatic niche into new cancer targets and novel therapies. The ultimate programmatic goal of TMM is to translate discoveries of the tumor microenvironment's pathophysiology into new cancer targets and appropriately targeted therapies for treating metastatic cancers. Two central themes encompass these goals: 1) Cancer cell-stroma interactions and 2) The metastatic niche. Despite its relatively recent establishment in late 2009, TMM is highly productive and collaborative in its basic and translational approaches to understanding the pathobiology of solid tumors, cancer cell-stroma interactions, the tumor microenvironment, and the metastatic niche. TMM has 25 full and 9 associate members from over 14 departments/divisions on the campuses of Indiana University School of Medicine, lU-Bloomington, and Notre Dame, including: Endocrinology, Dermatology, Biochemistry and Molecular Biology, Division of Hem/Onc (Adult and Peds), Pathology and Laboratory Medicine, Radiology, Anatomy and Cell Biology, Neonatal-Perinatal Medicine, Cellular and Integrative Physiology, Clinical Pharmacology, Medical and Molecular Genetics, OB/GYN, and Chemistry/Biochemistry (Notre Dame). Over this funding period, TMM members have published a total of 453 papers, of which 31.2% represent intra-programmatic collaborations, 35.7% represent interprogrammatic collaborations, and 24.7% represent inter-institutional collaborations. The Program has a total of $8.5M in current peer reviewed funding, with $4.3M from the NCI, $$2.6M from other NIH branches, $1.2M from the Department of Defense, $180K from the ACS, and $250K in other peer-reviewed funding.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
United States
Zip Code
Broxmeyer, Hal E; Pelus, Louis M (2014) Inhibition of DPP4/CD26 and dmPGE? treatment enhances engraftment of mouse bone marrow hematopoietic stem cells. Blood Cells Mol Dis 53:34-8
Blue, Emily K; DiGiuseppe, Robert; Derr-Yellin, Ethel et al. (2014) Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells. Pediatr Res 75:266-72
Miller, Kathy D; Althouse, Sandra K; Nabell, Lisle et al. (2014) A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007. Breast Cancer Res Treat 148:99-106
Chiorean, E Gabriela; Schneider, Bryan P; Akisik, Fatih M et al. (2014) Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 89:284-91
Nudelman, Kelly N H; Wang, Yang; McDonald, Brenna C et al. (2014) Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. PLoS One 9:e96713
Hocevar, Barbara A; Kamendulis, Lisa M; Pu, Xinzhu et al. (2014) Contribution of environment and genetics to pancreatic cancer susceptibility. PLoS One 9:e90052
Chitteti, Brahmananda Reddy; Kobayashi, Michihiro; Cheng, Yinghua et al. (2014) CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche. Blood 124:519-29
Chitteti, Brahmananda Reddy; Srour, Edward F (2014) Cell cycle measurement of mouse hematopoietic stem/progenitor cells. Methods Mol Biol 1185:65-78
Chang, Hua-Chen; Lewis, David; Tung, Chun-Yu et al. (2014) Soypeptide lunasin in cytokine immunotherapy for lymphoma. Cancer Immunol Immunother 63:283-95
Speth, Jennifer M; Hoggatt, Jonathan; Singh, Pratibha et al. (2014) Pharmacologic increase in HIF1* enhances hematopoietic stem and progenitor homing and engraftment. Blood 123:203-7

Showing the most recent 10 out of 83 publications